Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
0 this month

Showing 9341–9360 of 17,529 recalls

February 14, 2018· Fagron, Inc

Recalled Item: SyrSpend SF Suspending Base

The Issue: Microbial contamination of Non-Sterile Product; product contamination with

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 14, 2018· LEADIANT BIOSCIENCES, INC

Recalled Item: Cystaran (cysteamine ophthalmic solution) 0.44%

The Issue: Subpotent Drug: Out of specification for an active

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
February 13, 2018· Hetero Labs Limited Unit V

Recalled Item: Valacyclovir Tablets USP 1 gram

The Issue: Temperature Abuse: Valganciclovir Tablets USP 450 mg and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 13, 2018· Hetero Labs Limited Unit V

Recalled Item: Valganciclovir Tablets

The Issue: Temperature Abuse: Valganciclovir Tablets USP 450 mg and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 13, 2018· Nostrum Laboratories Inc

Recalled Item: Calcium Acetate Capsules

The Issue: Presence of Foreign Tablets/Capsules

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
February 9, 2018· Apace KY LLC

Recalled Item: Acyclovir Tablets

The Issue: Presence of Foreign Tablet/Capsule; cartons labeled to contain

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Nifedipine USP for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Calcipotriene BP (Monohydrate) for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Testosterone Cypionate USP (Micronized) for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Baclofen USP (Micronized) for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Cyclobenzaprine HCl USP for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Tadalafil USP (Monohydrate) for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Estradiol USP (Micronized) (Yam) for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Duloxetine HCl USP for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Sildenafil Citrate USP for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Tramadol HCl USP (CIV) for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Oxandrolone USP for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Estradiol Hemihydrate USP (Micronized) (Soy) for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Phentolamine Mesylate USP for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Prilocaine HCl USP for prescription compounding

The Issue: CGMP Deviations: Lack of stability data and controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund